Search

In the aftermath of China’s Cultural Revolution, as the surrounding “ridges of the Hills Everlasting” were crumbling, young students suddenly found a universe of ideas at their fingertips. Among those inspired by that moment was Xiankai Sun, Ph.D., now Director of the Cyclotron and Radiochemistry

Information for potential patients and enrollees for specific studies in the area of Lipodystrophy at UT Southwestern.

UT Southwestern offers rotations to medical students in Emergency Medicine specialties.

Meet the faculty of UT Southwestern's Department of Pediatrics

Research of interest and underway by faculty and staff affiliated with the Division of Thoracic Surgery here at UT Southwestern Medical Center.

Meet the residents in Orthopaedic Surgery at UT Southwestern.

Cores Three shared resource cores, including an Administrative and Outreach Core, a Biospecimen and Pathology Core, and a Data Science Core, are supporting all three Liver Cancer SPORE projects. Each core leverages already established UT Southwestern and Harold C. Simmons Comprehensive Cancer Center shared resources to develop infrastructure dedicated to liver research. CORE A: Administrative and Outreach The Administrative and Outreach Core (Core A) acts as the “hub” of oversight and management

Programs Career Enhancement Program The Career Enhancement Program (CEP) provides seed funding to support and foster careers of early-stage scientists interested in translational liver cancer research and to facilitate more established investigators refocusing their research towards this area. CEP funds career-enhancing pilot projects with the potential to generate groundbreaking discoveries that significantly improve liver cancer prevention, early detection, or treatment efficacy. Two to four

Projects The overarching goal of the Liver Cancer SPORE is to leverage innovative, groundbreaking basic science discoveries from UT Southwestern investigators to develop and translate personalized medical interventions that can significantly reduce liver cancer mortality. We particularly focus on hepatocellular carcinoma (HCC), the most common form (>85%) of liver cancer in Texas and the U.S. To accomplish this goal, we take a multi pronged approach, including prevention of incident HCC and

Meet the Team Directors Amit Singal, M.D. CORE A and Project 1 Liver Tumor Program and Chief of Hepatology Yujin Hoshida, M.D., Ph.D. CORE A, Project 1, Developmental Research Program Liver Tumor Translational Research Leaders Chul Ahn, Ph.D. CORE C Professor, Peter O'Donnell Jr. School of Public Health Suzanne Conzen, M.D. Career Enhancement Program Professor and Division Chief, Internal Medicine –Hematology and Oncology Purva Gopal, M.D. CORE B Associate Professor, Pathology David Hseih, M.D